JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Byzova, T. V.
Right arrow Articles by Plow, E. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Byzova, T. V.
Right arrow Articles by Plow, E. F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 43, Issue of October 24, 1997 pp. 27183-27188
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Networking in the Hemostatic System
INTEGRIN alpha IIbbeta 3 BINDS PROTHROMBIN AND INFLUENCES ITS ACTIVATION

(Received for publication, July 2, 1997, and in revised form, August 27, 1997)

Tatiana V. Byzova and Edward F. Plow

From the Joseph J. Jacobs Center for Thrombosis and Vascular Biology, Department of Molecular Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio 44195

Prothrombin activation is a pivotal event in thrombosis and hemostasis because thrombin can mediate fibrin formation and can activate and aggregate platelets. Platelet aggregation depends upon the binding of adhesive proteins to integrin alpha IIbbeta 3 on the platelet surface. In the present study, a novel interface between the blood coagulation system and platelets is demonstrated by showing that 1) prothrombin binds to alpha IIbbeta 3 and 2) this interaction accelerates prothrombin activation. Prothrombin bound to purified alpha IIbbeta 3 in a specific, saturable, and divalent cation-dependent manner. This interaction was inhibited by certain monoclonal antibodies to alpha IIbbeta 3, by the alpha IIbbeta 3 ligands fibrinogen and RGD peptides, but not by thrombin or unrelated proteins. Prothrombin also interacted with alpha IIbbeta 3 on resting and stimulated platelets as demonstrated by soluble ligand binding and platelet adhesion assays. Activation of prothrombin by Factor Xa alone or Factor Xa-Va was accelerated by alpha IIbbeta 3, and this enhancement was blocked by a monoclonal antibody that inhibited prothrombin binding to the receptor. Taken together, these data identify a previously unrecognized linkage between platelets and the blood coagulation system that may have a significant regulatory consequence.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
haematolHome page
A. Membre, D. Wahl, V. Latger-Cannard, J.-P. Max, P. Lacolley, T. Lecompte, and V. Regnault
The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies
Haematologica, April 1, 2008; 93(4): 566 - 573.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Lechner, I. Assfalg-Machleidt, S. Zahler, M. Stoeckelhuber, W. Machleidt, M. Jochum, and D. K. Nagler
RGD-dependent Binding of Procathepsin X to Integrin {alpha}vbeta3 Mediates Cell-adhesive Properties
J. Biol. Chem., December 22, 2006; 281(51): 39588 - 39597.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Shanmugam
Tirofiban and emergency coronary surgery
Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 546 - 550.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
R. Altman, A. Scazziota, S. Santoro, and C. Gonzalez
Abciximab Does Not Inhibit the Increase of Thrombin Generation Produced in Platelet-Rich Plasma In Vitro by Sodium Arachidonate or Tissue Factor
Clinical and Applied Thrombosis/Hemostasis, July 1, 2005; 11(3): 271 - 277.
[Abstract] [PDF]


Home page
Eur Heart JHome page
D. A. Morrow, S. A. Murphy, C. H. McCabe, N. Mackman, H. C. Wong, E. M. Antman, and on behalf of the PROXIMATE-TIMI 27 Investigators
Potent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): results of the PROXIMATE-TIMI 27 trial
Eur. Heart J., April 1, 2005; 26(7): 682 - 688.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Chen, S. De, D. S. Damron, W. S. Chen, N. Hay, and T. V. Byzova
Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice
Blood, September 15, 2004; 104(6): 1703 - 1710.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G.A. Stouffer and S.S. Smyth
Effects of Thrombin on Interactions Between {beta}3-Integrins and Extracellular Matrix in Platelets and Vascular Cells
Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 1971 - 1978.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Yamashita, Y. Asada, H. Sugimura, H. Yamamoto, K. Marutsuka, K. Hatakeyama, S. Tamura, Y. Ikeda, and A. Sumiyoshi
Contribution of von Willebrand Factor to Thrombus Formation on Neointima of Rabbit Stenotic Iliac Artery Under High Blood-Flow Velocity
Arterioscler. Thromb. Vasc. Biol., June 1, 2003; 23(6): 1105 - 1110.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. M. Monroe, M. Hoffman, and H. R. Roberts
Platelets and Thrombin Generation
Arterioscler. Thromb. Vasc. Biol., September 1, 2002; 22(9): 1381 - 1389.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Undas, K. Brummel, J. Musial, K. G. Mann, and A. Szczeklik
PlA2 Polymorphism of {beta}3 Integrins Is Associated With Enhanced Thrombin Generation and Impaired Antithrombotic Action of Aspirin at the Site of Microvascular Injury
Circulation, November 27, 2001; 104(22): 2666 - 2672.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Undas, K. Brummel, J. Musial, K. G. Mann, and A. Szczeklik
Blood coagulation at the site of microvascular injury: effects of low-dose aspirin
Blood, October 15, 2001; 98(8): 2423 - 2431.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Szczeklik, M. Sanak, A. Undas, P. F. Bray, P. Goldschmidt-Clermont, M. I. Furman, A. D. Michelson, M. R. Barnard, M. A. Mascelli, C. Hendrix, et al.
Platelet Glycoprotein IIIa PlA Polymorphism and Effects of Aspirin on Thrombin Generation Response
Circulation, February 13, 2001; 103 (6): e33 - e34.
[Full Text] [PDF]


Home page
BloodHome page
D. Dormann, K. J. Clemetson, and B. E. Kehrel
The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity
Blood, October 1, 2000; 96(7): 2469 - 2478.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
J. B. Bussel, T. J. Kunicki, and A. D. Michelson
Platelets: New Understanding of Platelet Glycoproteins and Their Role in Disease
Hematology, January 1, 2000; 2000(1): 222 - 240.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Pampori, T. Hato, D. G. Stupack, S. Aidoudi, D. A. Cheresh, G. R. Nemerow, and S. J. Shattil
Mechanisms and Consequences of Affinity Modulation of Integrin alpha Vbeta 3 Detected with a Novel Patch-engineered Monovalent Ligand
J. Biol. Chem., July 30, 1999; 274(31): 21609 - 21616.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. M. Scarborough, N. S. Kleiman, and D. R. Phillips
Platelet Glycoprotein IIb/IIIa Antagonists : What Are the Relevant Issues Concerning Their Pharmacology and Clinical Use?
Circulation, July 27, 1999; 100(4): 437 - 444.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. S. Cierniewski, T. Byzova, M. Papierak, T. A. Haas, J. Niewiarowska, L. Zhang, M. Cieslak, and E. F. Plow
Peptide Ligands Can Bind to Distinct Sites in Integrin alpha IIbbeta 3 and Elicit Different Functional Responses
J. Biol. Chem., June 11, 1999; 274(24): 16923 - 16932.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. D. Hu, C. A. White, S. Panzer-Knodle, J. D. Page, N. Nicholson, and J. W. Smith
A New Model of Dual Interacting Ligand Binding Sites on Integrin alpha IIbbeta 3
J. Biol. Chem., February 19, 1999; 274(8): 4633 - 4639.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
T. V. Byzova and E. F. Plow
Activation of alpha Vbeta 3 on Vascular Cells Controls Recognition of Prothrombin
J. Cell Biol., December 28, 1998; 143(7): 2081 - 2092.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. H. Tam, P. M. Sassoli, R. E. Jordan, and M. T. Nakada
Abciximab (ReoPro, Chimeric 7E3 Fab) Demonstrates Equivalent Affinity and Functional Blockade of Glycoprotein IIb/IIIa and {alpha}vß3 Integrins
Circulation, September 15, 1998; 98(11): 1085 - 1091.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. S. Williams, B. S. Coller, H. J. Vaananen, L. E. Scudder, S. K. Sharma, and J. D. Marmur
Activation of Platelets in Platelet-Rich Plasma by Rotablation Is Speed-Dependent and Can Be Inhibited by Abciximab (c7E3 Fab; ReoPro)
Circulation, August 25, 1998; 98(8): 742 - 748.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y. Suzuki, P. Hillyer, S. Miyamoto, S. Niewiarowski, L. Sun, A. K. Rao, S. Hollenbach, and L. H. Edmunds Jr
Integrilin prevents prolonged bleeding times after cardiopulmonary bypass
Ann. Thorac. Surg., August 1, 1998; 66(2): 373 - 381.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.